The Role of Heparin-Binding EGF-Like Growth Factor in Breast Cancer

reportActive / Technical Report | Accession Number: ADA322376 | Open PDF

Abstract:

Heparin-binding epidermal growth factor-like growth factor HB-EGF is a member of the EGF family which binds to and activates the EGF receptor. Its role in breast cancer, however, is unclear. We have studied the regulation of HB-EGF expression in nontransformed and transformed mammary epithelial cells. HB-EGF is induced by 12-0- tetradecanoylphorbol- 13-acetate TPA in most of the cell lines analyzed. In contrast with transforming growth factor alpha or amphiregulin, HB-EGF is not induced by estrogen or progesterone in any of the estrogen responsive, estrogen receptor positive breast cancer cell lines examined. HB-EGF RNA levels are induced by EG-related peptides in the spontaneously immortalized mammary epithelial cell line.

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution:
Approved For Public Release
Distribution Statement:
Approved For Public Release; Distribution Is Unlimited.

RECORD

Collection: TR
Identifying Numbers
Subject Terms